In vascular proliferative disorders, such as cancer and diabetic retinopathy, the blockade of Ang-2 may lead to anti-angiogenesis from Ang-2 inhibition and the inhibition of other angiogenic factors whose activities are mediated by Ang-2 (46). This evidence concerns the gene ANGPT2 and cancer.